tiprankstipranks
Trending News
More News >
Sartorius Stedim Biotech (FR:DIM)
:DIM
France Market

Sartorius Stedim Biotech (DIM) Financial Statements

Compare
18 Followers

Sartorius Stedim Biotech Financial Overview

Sartorius Stedim Biotech's market cap is currently €17.62B. The company's EPS TTM is €1.12; its P/E ratio is 70.33; and it has a dividend yield of 0.31%. Sartorius Stedim Biotech is scheduled to report earnings on February 3, 2026, and the estimated EPS forecast is €1.27. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 2.78B€ 2.78B€ 3.49B€ 2.89B€ 1.91B
Gross Profit€ 1.21B€ 1.23B€ 1.82B€ 1.55B€ 1.00B
Operating Income€ 370.60M€ 484.50M€ 1.10B€ 912.67M€ 471.81M
EBITDA€ 670.50M€ 755.70M€ 1.33B€ 811.96M€ 569.20M
Net Income€ 175.10M€ 309.70M€ 876.10M€ 414.40M€ 335.93M
Balance Sheet
Cash & Short-Term Investments€ 688.80M€ 126.10M€ 133.00M€ 237.35M€ 69.61M
Total Assets€ 8.26B€ 7.74B€ 5.07B€ 3.95B€ 3.07B
Total Debt€ 2.87B€ 3.68B€ 1.14B€ 625.52M€ 586.78M
Net Debt€ 2.19B€ 3.57B€ 1.03B€ 401.89M€ 527.02M
Total Liabilities€ 4.23B€ 5.07B€ 2.55B€ 2.22B€ 1.59B
Stockholders' Equity€ 3.99B€ 2.64B€ 2.45B€ 1.66B€ 1.46B
Cash Flow
Free Cash Flow€ 475.30M€ 156.10M€ 181.70M€ 371.98M€ 257.69M
Operating Cash Flow€ 815.10M€ 629.70M€ 612.30M€ 695.97M€ 416.88M
Investing Cash Flow€ -340.00M€ -2.72B€ -957.50M€ -465.23M€ -621.12M
Financing Cash Flow€ 84.90M€ 1.99B€ 220.70M€ -69.27M€ 234.07M
Currency in EUR

Sartorius Stedim Biotech Earnings and Revenue History

Sartorius Stedim Biotech Debt to Assets

Sartorius Stedim Biotech Cash Flow

Sartorius Stedim Biotech Forecast EPS vs Actual EPS